FS
BIIB icon

Financial Symmetry’s Biogen BIIB Stock Holding History

Financial Symmetry’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Hold
1,248
– – 0.09% 53
2026
Q1 		$236K Buy
+1,248
New +$230K 0.08% 53

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Financial Symmetry's BIIB Position: Q2 2026 in Review

Financial Symmetry held its Biogen (BIIB) position steady in Q2 2026 at 1,248 shares worth $270K. The position accounts for 0.09% of the portfolio, ranked #53.

Financial Symmetry first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Financial Symmetry held 1,248 shares of Biogen worth $270K as of Q2 2026.
  • Financial Symmetry left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.09% of Financial Symmetry's portfolio in Q2 2026, its #53 holding.
  • Financial Symmetry first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Financial Symmetry's 13F filing for Q2 2026, filed 14 Jul 2026.